Pascale Andre
Marseille, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
PD-1+ NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immune-checkpoint blockade.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 13, 2024
Population Pharmacokinetics of Monalizumab in Patients With Advanced Solid Tumors.
Journal: Journal of clinical pharmacology
Published: November 09, 2022
CD73-Mediated Immunosuppression Is Linked to a Specific Fibroblast Population That Paves the Way for New Therapy in Breast Cancer.
Journal: Cancers
Published: October 16, 2021
Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19.
Journal: Cellular & molecular immunology
Published: June 15, 2020
Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis.
Journal: Nature
Published: April 29, 2020
Natural killer cells: promising targets in cancer therapy
Journal: Medecine sciences : M/S
Published: January 07, 2020
Monalizumab: inhibiting the novel immune checkpoint NKG2A.
Journal: Journal for immunotherapy of cancer
Published: May 31, 2019
Targeting natural killer cells in solid tumors.
Journal: Cellular & molecular immunology
Published: January 15, 2019
NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines.
Journal: Cell
Published: June 14, 2018
A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies.
Journal: Oncotarget
Published: October 05, 2017
Kinetics of Cytotoxic Lymphocytes Reconstitution after Induction Chemotherapy in Elderly AML Patients Reveals Progressive Recovery of Normal Phenotypic and Functional Features in NK Cells.
Journal: Frontiers in immunology
Published: October 25, 2016
Last Updated: 09/26/2026